NOVA ERA SILICON
28/09/2001
NOVA ERA SILICON S.A
Registrada824171047
Minerais e metais comuns e suas ligas, principalmente ferro, aço e ferro-silício, no estado em bruto ou semimanufaturado, resultante da operação e produção de suas fábricas
NOVA ERA SILICON S.A
AtivaRegistrada
824171047Especificação: Minerais e metais comuns e suas ligas, principalmente ferro, aço e ferro-silício, no estado em bruto ou semimanufaturado, resultante da operação e produção de suas fábricas
11/01/2022
PHARMAVANT 8, INC.
Registrada501663459
Cl. 5: Pharmaceutical preparations for human use biologic preparations for medical and therapeutic purposes Pharmaceutical preparations for human use for the treatment of central nervous system, neurological, dementia, dermatological, metabolic, hematologic, infectious, auto-immune, immune deficiency, genetic, hepatological, cardiometabolic, urological, oncological, endocrine and endocrine-related, gynecological, ophthalmological, respiratory, cardiac, and pulmonary disorders, diseases and conditions Anti-cancer preparations Pharmaceutical preparations and substances for the prevention of cancer Pharmaceutical preparations and substances for the treatment of cancer Pharmaceutical preparations for the treatment of cancer Anti-cancer preparations of chemical origin Anti-cancer preparations of plant origin Anti-cancer preparations of microbial origin Biopharmaceuticals for the treatment of cancer Compounds for treating cancer Biological preparations for medical purposes Biological preparations for the treatment of cancer Viral vaccines Pharmaceutical preparations for the treatment of viral diseases Pharmaceutical preparations for the treatment of inflammatory diseases Pharmaceutical preparations for the prevention of inflammatory diseases Pharmaceuticals Chemico-pharmaceutical preparations Antibacterial pharmaceuticals Anti-microbial preparations Chemical preparations for medical purposes Chemical preparations for pharmaceutical purposes Vaccines Vaccine adjuvants Pharmaceutical preparations comprising small molecules for degrading disease-causing cellular proteins for treatment in the field of oncology pharmaceutical and biological preparations for treatment and prevention of cancer and for the treatment and prevention of auto-immune diseases and disorders and central nervous system and neurological diseases and disorders Biological preparations for the treatment of viral infections Biological preparations for the treatment of inflammatory conditions Biological preparations for the treatment of age-related degenerative diseases Biological preparations for the treatment of microbial, fungal and viral infections Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of age-related degenerative diseases and cancers Pharmaceutical preparations for the treatment and prevention of cancer Pharmaceutical preparations for the treatment and prevention of viral infections Pharmaceutical preparations for the treatment and prevention of microbial, fungal and viral infections Pharmaceutical preparations for the treatment and prevention of inflammatory conditions Pharmaceutical preparations for the treatment and prevention of age-related degenerative diseases Vaccine preparations · Cl. 42: Scientific and technological services and research and design relating thereto research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials biomedical research and development Research and development in the pharmaceutical and biotechnology fields Research and development of new products Research and development of new products for others Research and development of pharmaceuticals for the treatment of age-related diseases and cancer Research and development of vaccines and medicines Research and development services in the field of antibodies Biochemical research and development Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science Pharmaceutical research and development Product research and development Scientific research and development Pharmaceutical product development for new small molecules aimed at degrading disease-causing cellular proteins for treatment in the field of oncology · Cl. 44: Providing health and medical information providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions
PHARMAVANT 8, INC.
AtivaRegistrada
501663459Especificação: Cl. 5: Pharmaceutical preparations for human use biologic preparations for medical and therapeutic purposes Pharmaceutical preparations for human use for the treatment of central nervous system, neurological, dementia, dermatological, metabolic, hematologic, infectious, auto-immune, immune deficiency, genetic, hepatological, cardiometabolic, urological, oncological, endocrine and endocrine-related, gynecological, ophthalmological, respiratory, cardiac, and pulmonary disorders, diseases and conditions Anti-cancer preparations Pharmaceutical preparations and substances for the prevention of cancer Pharmaceutical preparations and substances for the treatment of cancer Pharmaceutical preparations for the treatment of cancer Anti-cancer preparations of chemical origin Anti-cancer preparations of plant origin Anti-cancer preparations of microbial origin Biopharmaceuticals for the treatment of cancer Compounds for treating cancer Biological preparations for medical purposes Biological preparations for the treatment of cancer Viral vaccines Pharmaceutical preparations for the treatment of viral diseases Pharmaceutical preparations for the treatment of inflammatory diseases Pharmaceutical preparations for the prevention of inflammatory diseases Pharmaceuticals Chemico-pharmaceutical preparations Antibacterial pharmaceuticals Anti-microbial preparations Chemical preparations for medical purposes Chemical preparations for pharmaceutical purposes Vaccines Vaccine adjuvants Pharmaceutical preparations comprising small molecules for degrading disease-causing cellular proteins for treatment in the field of oncology pharmaceutical and biological preparations for treatment and prevention of cancer and for the treatment and prevention of auto-immune diseases and disorders and central nervous system and neurological diseases and disorders Biological preparations for the treatment of viral infections Biological preparations for the treatment of inflammatory conditions Biological preparations for the treatment of age-related degenerative diseases Biological preparations for the treatment of microbial, fungal and viral infections Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of age-related degenerative diseases and cancers Pharmaceutical preparations for the treatment and prevention of cancer Pharmaceutical preparations for the treatment and prevention of viral infections Pharmaceutical preparations for the treatment and prevention of microbial, fungal and viral infections Pharmaceutical preparations for the treatment and prevention of inflammatory conditions Pharmaceutical preparations for the treatment and prevention of age-related degenerative diseases Vaccine preparations · Cl. 42: Scientific and technological services and research and design relating thereto research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials biomedical research and development Research and development in the pharmaceutical and biotechnology fields Research and development of new products Research and development of new products for others Research and development of pharmaceuticals for the treatment of age-related diseases and cancer Research and development of vaccines and medicines Research and development services in the field of antibodies Biochemical research and development Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science Pharmaceutical research and development Product research and development Scientific research and development Pharmaceutical product development for new small molecules aimed at degrading disease-causing cellular proteins for treatment in the field of oncology · Cl. 44: Providing health and medical information providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions
CÊRAVINIL SILICONIO MEU LUSTRAMÓVEIS
08/08/1990
WALTER PINTO LANCIOTE ME
Encerrada815609590
Preparados para lavanderia, produtos e instrumentos de limpeza, exceto os de uso pessoal e industrial
WALTER PINTO LANCIOTE ME
InativaEncerrada
815609590Especificação: Preparados para lavanderia, produtos e instrumentos de limpeza, exceto os de uso pessoal e industrial